` IRMD (IRadimed Corp) vs S&P 500 Comparison - Alpha Spread

IRMD
vs
S&P 500

Over the past 12 months, IRMD has outperformed S&P 500, delivering a return of 28% compared to the S&P 500's 8% growth.

Stocks Performance
IRMD vs S&P 500

Loading
IRMD
S&P 500
Add Stock

Performance Gap
IRMD vs S&P 500

Loading
IRMD
S&P 500
Difference

Performance By Year
IRMD vs S&P 500

Loading
IRMD
S&P 500
Add Stock

Competitors Performance
IRadimed Corp vs Peers

IRadimed Corp
Glance View

Market Cap
673.2m USD
Industry
Health Care

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

IRMD Intrinsic Value
33.7 USD
Overvaluation 36%
Intrinsic Value
Price
Back to Top